| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.75B | 132.70B | 138.86B | 148.38B | 177.45B | 119.98B |
| Gross Profit | 11.95B | 10.00B | 9.29B | 16.51B | 22.57B | 6.61B |
| EBITDA | 12.39B | 11.68B | 10.60B | 18.56B | 24.88B | 7.45B |
| Net Income | 4.63B | 4.05B | 3.44B | 9.68B | 14.52B | 9.74B |
Balance Sheet | ||||||
| Total Assets | 88.19B | 85.56B | 78.86B | 85.99B | 89.90B | 85.37B |
| Cash, Cash Equivalents and Short-Term Investments | 2.15B | 3.67B | 3.21B | 10.22B | 11.77B | 10.84B |
| Total Debt | 34.33B | 34.36B | 28.76B | 28.50B | 27.91B | 26.90B |
| Total Liabilities | 64.76B | 61.47B | 54.35B | 54.59B | 54.82B | 51.79B |
| Stockholders Equity | 16.75B | 17.31B | 17.75B | 24.40B | 27.71B | 26.21B |
Cash Flow | ||||||
| Free Cash Flow | 5.70B | 4.77B | 6.13B | 12.23B | 13.94B | 2.90B |
| Operating Cash Flow | 9.44B | 8.25B | 8.66B | 14.12B | 16.36B | 4.36B |
| Investing Cash Flow | -6.09B | -6.27B | 1.53B | -3.10B | 623.00M | 14.80B |
| Financing Cash Flow | -5.01B | -1.52B | -12.43B | -14.21B | -13.65B | -14.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $12.62B | 4.35 | 13.11% | 4.26% | -1.08% | ― | |
74 Outperform | $14.58B | 3.45 | 16.51% | 6.88% | 37.27% | -29.09% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | $74.45B | 35.24 | 27.33% | 2.24% | -1.29% | 114.86% | |
63 Neutral | $74.45B | 14.57 | 17.63% | 2.74% | -2.53% | 385.02% | |
57 Neutral | $5.00B | 7.04 | 8.35% | 4.14% | -4.33% | ― | |
56 Neutral | $70.64B | 88.46 | 14.72% | 3.68% | -1.33% | 130.72% |